BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Analog Inflation Devices Market: Rise in prevalence of cardiovascular disorders is likely to drive the global market

  Analog inflation devices are used to measure the pressure in stents and balloons during cardiac surgeries. These devices have high pressure flexible tubing and angled pressure gauge.

  February 15, 2022

   · 

  5 min read
• Femoral Head Prostheses Market: Rise in prevalence of degenerative joint disorders to drive the market

  Hip is one of the significant supporting joints of the body that functions by joining the femurs with the pelvis. Hip can suffer damage in old age, and thus, patients undergo hip replacement surgeries.

  February 15, 2022

   · 

  5 min read
• BioMidwest

  SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

  SynerFuse, Inc., today announced that the U.S. Patent & Trademark Office (USPTO) has issued U.S. Patent Number 11,247,046 entitled Methods and Systems for Implanting a Neuromodulation System at a Surgically Open Spinal Treatment Site.

  February 15, 2022

   · 

  3 min read
• Photosensitizer Drugs Market: Rise in the Burden of Dermatology Disorders to Drive the Market

  Photosensitizer drugs or photosensitizing agents are used in the photodynamic therapy (PDT) for the treatment of cancer.

  February 15, 2022

   · 

  5 min read
• Tourniquet Cuffs Market: Rising Prevalence of Lower Limb Injuries Aids in the Growth of the Market

  Tourniquets are majorly employed in orthopedic and plastic surgeries related to limbs.

  February 15, 2022

   · 

  5 min read
• BioMidwest

  Oligon to Present at Biocom Global Life Science Partnering Conference

  Oligon™ Inc. announced that Dr. Spyro Mousses, Chief Executive Officer of Oligon, will be presenting at the 12th Annual Biocom Global Life Science Partnering Conference.

  February 15, 2022

   · 

  1 min read
• Job Trends

  New Post-Marketing Safety Analysis Shows Rate of Hearing-Related Events Associated with TEPEZZA® (teprotumumab-trbw) Comparable with Clinical Trial Observations

  Horizon Therapeutics plc (Nasdaq: HZNP) today announced results from a new post-marketing safety analysis of hearing events associated with TEPEZZA for the treatment of Thyroid Eye Disease (TED).

  February 15, 2022

   · 

  7 min read
• Pharm Country

  Egret Therapeutics completes oversubscribed pre-A financing round

  Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion of its pre-A financing.

  February 15, 2022

   · 

  1 min read
• Global Neonatal Phototherapy Devices Market Growth and Competitive Analysis

  The global neonatal phototherapy devices market has tread along a healthy growth path in the recent years and continue to expand at a promising pace.

  February 15, 2022

   · 

  7 min read
• BioMidwest

  Stryker to participate in Cowen 42nd Annual Health Care Conference

  Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time.

  February 15, 2022

   · 

  1 min read